Antiverse
Developer of a drug discovery platform designed to predict antibody-antigen binding and provide antibody drug candidates against difficult targets. The company's platform uses machine learning and cel...
Valuation
$0
Share Price
N/A
Total Raised
$8.3M
Last Round
N/A